Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Therapeutics

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2008.09.001PMID 18840368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age, body mass index, and menstrual cycle influence young women’s heart rate variability

  2005cited by this paper
• Influence of menstrual cycle on baroreflex control of heart rate: comparison with male volunteers.

  2003cited by this paper
• Vasovagal Syncope

  2000cited by this paper
• Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy.

  1999cited by this paper
• A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension

  1998cited by this paper
• Midodrine: a role in the management of neurocardiogenic syncope

  1998cited by this paper
• Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans.

  1998cited by this paper
• Midodrine

  1998cited by this paper
• Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia.

  1997cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use

  1996cited by this paper
• Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia.

  1995cited by this paper
• Pathophysiological Aspects of Neurocardiogenic Syncope: Current Concepts and New Perspectives

  1995cited by this paper
• Update on the evaluation, pathogenesis, and management of neurogenic orthostatic hypotension: introduction.

  1995cited by this paper
• N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

  1994cited by this paper
• Autonomic Imbalance Assessed by Heart Rate Variability Analysis in Vasovagal Syncope

  1994cited by this paper
• Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.

  1993cited by this paper
• Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers.

  1993cited by this paper
• Gutron treatment of patients suffering from essential orthostatic hypotony. Part Two--Autonomic system investigation.

  1993cited by this paper
• Cardiovascular parameters and catecholamines in volunteers during passive orthostasis. Influence of antihypotensive drugs.

  1992cited by this paper
• Heart rate variability. Frequency domain analysis.

  1992cited by this paper
• Long-acting alpha 1-adrenoceptive sympathomimetic agent suppresses sympathetic outflow to muscles in humans.

  1991cited by this paper
• Reflexes from the heart.

  1991cited by this paper
• Different behaviour of the N-terminal and C-terminal fragment of proatrial natriuretic factor in plasma of healthy subjects as well as of patients with cirrhosis.

  1990cited by this paper
• Prolonged low dose infusion of atrial natriuretic factor in essential hypertension.

  1990cited by this paper
• Simultaneous Measurement of Plasma Catecholamine (Norepinephrine, Epinephrine, and Dopamine) and Free N—Methyl Dopamine (Epinine) Levels, by HPLC with Electrochemical Detection

  1990cited by this paper
• Midodrine

  1989cited by this paper
• Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.

  1988cited by this paper
• Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension.

  1988cited by this paper
• Reflex activation of sympathetic nervous system by ANF in humans.

  1988cited by this paper
• EFFECTS OF ANGIOTENSIN AND NORADRENALINE ON ATRIAL NATRIURETIC PEPTIDE LEVELS IN MAN

  1987cited by this paper
• The plasma release of atrial natriuretic peptide in man.

  1986cited by this paper
• Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.

  1986cited by this paper
• Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.

  1986cited by this paper
• Pharmacodynamics of midodrine, an antihypotensive agent

  1986cited by this paper
• A new technique for the study of vascular presynaptic receptors in freely moving rats.

  1986cited by this paper
• Responses of abdominal vascular capacitance to stimulation of splachnic nerves.

  1976cited by this paper
• Reflexes from the heart.

  1975cited by this paper
• Catecholamines in vasovagal fainting.

  1965cited by this paper
• Comparative studies on the adrenergic neuro-hormonal control of resistance and capacitance blood vessels in the cat.

  1960cited by this paper

• Electrocardiographic changes in transgender patients on gender-affirming hormone replacement therapy.

  2025cites this paper
• The Programmed Placebo Effect in Patients with Syncope: Preliminary Clinical and Nanostructural Insights with a Hypothetical Quantum-Level Interpretation

  2025cites this paper
• Midodrine for the early liberation from vasopressor support in the ICU (LIBERATE): A Vanguard Randomized Clinical Trial

  2025cites this paper
• Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery

  2024cites this paper
• Finding the Balance: Review of Pharmacological Management of Orthostatic Hypotension in Patients With Parkinson's Disease.

  2024cites this paper
• Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU: A Systematic Review and Meta-Analysis

  2024cites this paper
• Oral midodrine for prophylaxis against post-spinal anesthesia hypotension during hip arthroplasty in elderly population: a randomized controlled trial

  2024cites this paper
• LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial

  2022cites this paper
• Midodrine use in critically ill patients: a narrative review

  2022cites this paper
• Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis

  2022cites this paper
• Biomarkers and Hemodynamic Parameters in the Diagnosis and Treatment of Children with Postural Tachycardia Syndrome and Vasovagal Syncope

  2022cites this paper
• Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study

  2020cites this paper
• Pharmacologic treatment of orthostatic hypotension.

  2020cites this paper
• 200: IMPACT OF ORAL MIDODRINE ON DURATION OF INTRAVENOUS VASOPRESSOR THERAPY

  2018cites this paper
• A novel, sensitive and selective method of UPLC/MS-MS for rapid simultaneous determination of midodrine and its active metabolite desglymidodrine in human plasma: Application to support bioequivalence study in healthy human volunteers.

  2016cites this paper
• Oral Midodrine Hydrochloride for Prevention of Orthostatic Hypotension during Early Mobilization after Hip Arthroplasty: A Randomized, Double-blind, Placebo-controlled Trial

  2015cites this paper
• Midodrine in patients with spinal cord injury and anejaculation: A double-blind randomized placebo-controlled pilot study

  2015cites this paper
• Development and validation of LC-MS/MS assay for the determination of the prodrug Midodrine and its active metabolite Desglymidodrine in plasma of ascitic patients: Application to individualized therapy and comparative pharmacokinetics.

  2015influential citation
• Vasovagal syncope: an update on the latest pharmacological therapies

  2015influential citation
• Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children.

  2014cites this paper
• 50 years ago in the Journal of Pediatrics: the pattern of hearing following acute otitis media.

  2014cites this paper
• Therapy for diabetic neuropathy: an overview.

  2014cites this paper
• Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.

  2013cites this paper
• Orthostatic hypotension in older people

  2013cites this paper
• Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach.

  2013cites this paper
• HPLC analysis of midodrine and desglymidodrine in culture medium: evaluation of static and shaken conditions on the biotransformation by fungi.

  2013cites this paper
• Midodrine, Adrenergic Agonists and Antagonists

  2012cites this paper
• Rationale for the prevention of syncope trial IV: assessment of midodrine

  2012cites this paper
• Ajuste farmacológico en una paciente diabética con hipotensión ortostática e hipertensión arterial nocturna

  2011cites this paper
• Medication adjustment in a diabetic patient with orthostatic hypotension and nocturnal arterial hypertension.

  2011cites this paper
• Treatment of dysautonomia in extrapyramidal disorders

  2011cites this paper
• Therapie autonomer Dysfunktion bei Patienten mit extrapyramidalen Erkrankungen

  2010cites this paper
• Review: Treatment of dysautonomia in extrapyramidal disorders

  2010cites this paper
• [Treatment of autonomic dysfunction in patients with extrapyramidal disorders].

  2010cites this paper
• Response to chronic systolic heart failure, guideline-directed medical therapy, and systemic hypotension-less pressure but maybe more risk (does this clinical scenario need more discussion?).

  2009cites this paper
• α‐Adrenoceptor agonists for the treatment of vasovagal syncope: a meta‐analysis of worldwide published data

  2009cites this paper
• Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study

  2009cites this paper
• Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).

  2009cites this paper